The role of tyrosine kinase inhibitors (TKIs) as adjuvant treatment for renal cancer. Where do we stand today?

J BUON. 2017 Nov-Dec;22(6):1608-1610.
No abstract available

MeSH terms

  • Combined Modality Therapy
  • Enzyme Inhibitors / therapeutic use*
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / surgery
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / prevention & control
  • Protein-Tyrosine Kinases / antagonists & inhibitors*

Substances

  • Enzyme Inhibitors
  • Protein-Tyrosine Kinases